SARS-CoV-2

While Americans were (sort of) celebrating the Fourth of July, the coronavirus kept raging on. Some relevant developments and analysis have occurred in the past few days that might shed a little more light on how the pandemic will unfold.

ACSH advisor Dr.

Several months into the coronavirus pandemic, we still don't have a good understanding of SARS-CoV-2. The often contradictory information we get from scientists and public health officials reflects this.

There are a plethora of drugs and vaccines in the pipeline to treat or prevent COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2. How many of them are likely to be successful?

The novel coronavirus, SARS-CoV-2, has been the source of never-ending surprises, all of which have been very bad.

As cities and states across America slowly reopen for business, our leaders claim to be "following the science" as they lift restrictions.

The novel coronavirus, officially dubbed SARS-CoV-2, and the disease it causes (COVID-19) have continued to surprise all of us. And the surprises have been uniformly negative.

As of today, the American death toll from COVID-19 stands at more than 69,000, according to Johns Hopkins.

This article was originally published at Geopolitical Futures. The original is here.

The latest news on coronavirus has been mixed.